Myocardial β-Catenin-BMP2 signaling promotes mesenchymal cell proliferation during endocardial cushion formation

J Mol Cell Cardiol. 2018 Oct:123:150-158. doi: 10.1016/j.yjmcc.2018.09.001. Epub 2018 Sep 8.

Abstract

Abnormal endocardial cushion formation is a major cause of congenital heart valve disease, which is a common birth defect with significant morbidity and mortality. Although β-catenin and BMP2 are two well-known regulators of endocardial cushion formation, their interaction in this process is largely unknown. Here, we report that deletion of β-catenin in myocardium results in formation of hypoplastic endocardial cushions accompanying a decrease of mesenchymal cell proliferation. Loss of β-catenin reduced Bmp2 expression in myocardium and SMAD signaling in cushion mesenchyme. Exogenous BMP2 recombinant proteins fully rescued the proliferation defect of mesenchymal cells in cultured heart explants from myocardial β-catenin knockout embryos. Using a canonical WNT signaling reporter mouse line, we showed that cushion myocardium exhibited high WNT/β-catenin activities during endocardial cushion growth. Selective disruption of the signaling function of β-catenin resulted in a cushion growth defect similar to that caused by the complete loss of β-catenin. Together, these observations demonstrate that myocardial β-catenin signaling function promotes mesenchymal cell proliferation and endocardial cushion expansion through inducing BMP signaling.

Keywords: BMP; Congenital heart valve disease; Endocardial cushion formation; β-Catenin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / metabolism*
  • Cell Proliferation
  • Endocardial Cushions / embryology
  • Endocardial Cushions / metabolism*
  • Endocardium / metabolism
  • Mesoderm / cytology
  • Mesoderm / metabolism
  • Mice
  • Models, Biological
  • Myocardium / metabolism*
  • Organogenesis*
  • Paracrine Communication
  • Rats
  • Signal Transduction*
  • Wnt Signaling Pathway
  • beta Catenin / metabolism*

Substances

  • Bone Morphogenetic Protein 2
  • beta Catenin